Azole-resistance in Aspergillus
NCT03443336 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2021-06-03
Summary
Prospective multi-center surveillance study on the prevalence of azole-resistant Aspergillus spp. in clinical isolates of patients with pulmonary colonization or invasive infections in Switzerland
Conditions
- Pulmonary Aspergillosis
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Nina Khanna, Prof MD · University Hospital, Basel, Switzerland
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-01
- Primary Completion
- 2019-06-30
- Completion
- 2021-06-02
Countries
- Switzerland
Study Locations
More Related Trials
-
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
NCT00754273 ·Status: COMPLETED
-
Nasal Carrying by Staphylococcus Aureus ST398 Strains in Community and Hospital Settings
NCT03869255 ·Status: UNKNOWN
-
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
NCT04503252 ·Status: COMPLETED
-
Inflammation, Intracellular Invasion and Colonization of the Nasal Mucosa by Staphylococcus Aureus
NCT04469348 ·Status: COMPLETED ·Phase: NA
-
State of Play of Non-tuberculous Mycobacteria in Alsace
NCT06185166 ·Status: RECRUITING
-
A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections
NCT02355015 ·Status: UNKNOWN
-
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522 ·Status: UNKNOWN
-
A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
NCT00002085 ·Status: COMPLETED ·Phase: NA
-
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.
NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3
-
S. Aureus, Skin and Soft Tissue Infections
NCT02796742 ·Status: COMPLETED
-
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne
NCT02557568 ·Status: COMPLETED ·Phase: NA
-
Staphylococcus Aureus Nasal Carriage
NCT02796690 ·Status: COMPLETED
-
Advanced Understanding of Staphylococcus Aureus Infections in Europe - Surgical Site Infections
NCT02935244 ·Status: COMPLETED
-
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
NCT00622882 ·Status: UNKNOWN ·Phase: NA
-
Burden of Staphylococcus Lugdunensis Infections in Hospitalized Patients
NCT04318262 ·Status: UNKNOWN
-
Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery
NCT02595112 ·Status: COMPLETED ·Phase: NA
-
Microbiological Characterization and Nasal Carriage Rates of Methicillin Resistant Staphylococcus Aureus (MRSA) in Vancouver Downtown Eastside
NCT00247871 ·Status: COMPLETED
-
Obtaining and Storing Human Blood, Urine, and Fecal Samples for Spirochete-Related Epidemiological Research
NCT01089153 ·Status: COMPLETED
-
Azithromycin a Treatment for Pulmonary Sarcoidosis
NCT04020380 ·Status: COMPLETED ·Phase: PHASE2
-
Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex
NCT00298922 ·Status: UNKNOWN ·Phase: PHASE2
-
Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers
NCT00990145 ·Status: COMPLETED ·Phase: PHASE1
-
Hospital Acquired and Community Acquired MRSA in GI Lab
NCT00577343 ·Status: WITHDRAWN
-
Trial of Antimycobacterial Therapy in Sarcoidosis
NCT01074554 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)
NCT02284555 ·Status: COMPLETED ·Phase: PHASE4
-
Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
NCT04677543 ·Status: COMPLETED ·Phase: PHASE3